You now have access to all the content in the PAREXEL Access Hub. We look forward to engaging with you.
We will be in touch shortly.
Please complete our registration form to continue.
Developing a successful yet sustainable and defensible international strategy for pricing for pharmaceuticals is becoming an increasingly more complex challenge worldwide. With many payers across the globe opting for a different approach to value measurement, it can be difficult to realize the best price to maximize revenue.
Price optimization of just 1% is the equivalent to a 10% increase in profit, yet most pharmaceutical companies only award themselves an average of just 56% for the effectiveness of their current pricing function. To develop a global pricing strategy, it’s important for companies to overhaul outdated models in favour of new ones which:
• Integrate health economics early
• Generate evidence to demonstrate value and optimize price
• Anticipate and manage the “price waterfall”
• Devise the optimal launch sequence
• Monitor and respond to price fluctuations post-launch
In this paper we will discuss the five requirements for local affiliates to conduct credible observational research,…
Pricing & Reimbursement